Trial Oversight Spotlight #16: Ross Jackson
In this episode:
In this episode, Tom Lazenby interviews Ross Jackson, a patient recruitment consultant, discussing the evolving landscape of patient recruitment in clinical trials. They explore the importance of effective recruitment strategies, the role of AI, common misconceptions, and the significance of protocol design. Ross emphasizes the need for sponsors to take responsibility for recruitment and the importance of governance and oversight in the process.
Key takeaways:
- Patient recruitment often fails due to a combination of factors
- AI is being used to streamline patient recruitment processes
- Sponsors need to take an active role in patient recruitment strategies
- Patient experience should be prioritized in recruitment efforts
- Effective governance and oversight are essential for successful recruitment
Time stamps:
- – Introduction to Patient Recruitment Consulting
- – The Evolution of Patient Recruitment Strategies
- – Innovations in Patient Recruitment: The Role of AI
- – Understanding the Role of Sponsors and CROs
- – Common Misconceptions in Patient Recruitment
- – The Importance of Protocol Design
- – Trends in Patient-Centric Approaches
- – Governance and Oversight in Recruitment
- – Measuring Recruitment Success: Signals and Metrics
- – Final Thoughts and Key Takeaways
Guest Bio
Ross Jackson
Patient Recruitment Specialist and Author
Ross Jackson is a patient recruitment specialist consultant and author of the books The Patient Recruitment Conundrum and Patient Recruitment for Clinical Trials using Facebook Ads.
Having started out with digital marketing in 1998, Ross quickly developed a specialty in the healthcare niche, evolving into a focus on clinical trials and the problems of patient recruitment and retention.
Over the years Ross branched out from the purely digital and now operates in an advisory capacity helping sponsors, CROs, sites, solutions providers, and others in the industry to improve their patient recruitment and retention capabilities - having advised and consulted on over 100 successful projects.
Host Bio
Tom is running the Trial Oversight Spotlight Interview Series where he meets with a variety of colleagues working in clinical research. They discuss a selection of the most important topics and decisions that are currently being navigated by all types of organisations delivering research.
Tom has spent over a decade in Clinical Trials Operations and Quality Assurance and has experienced the impact that suboptimal vendor oversight and vendor non-compliance can have on the quality of clinical trials. Mayet is the solution to fix this.